Insights into Muscle Contraction Derived from the Effects of Small-Molecular Actomyosin-Modulating Compounds

Area of Science:

• Biophysics
• Cellular Mechanics
• Biomolecular Modeling

Background:

• Bottom-up mechanokinetic models aim to predict actomyosin ensemble function from isolated protein kinetics.
• General utility requires models to predict altered actomyosin kinetics, such as in disease states.

Purpose of the Study:

• To test and refine a mechanokinetic model's ability to predict actomyosin ensemble function under modified kinetic conditions.
• To improve the model's quantitative accuracy for drug effects and physiological variations.

Main Methods:

• Validated a mechanokinetic model against known physiological phenomena and drug effects (blebbistatin, MgATP).
• Systematically adjusted model parameters, including power stroke sub-stroke amplitudes and cross-bridge attachment rates, to match amrinone effects.
• Employed Monte Carlo simulations to analyze force-velocity data from small myosin ensembles.

Main Results:

• The model qualitatively predicted effects of various drugs and MgATP concentrations.
• Parameter adjustments, including increased second sub-stroke amplitude (1 nm to 2.2 nm) and doubled attachment rate, improved amrinone effect prediction.
• The modified model accurately predicted normal physiological ensemble function and force-velocity relationships for small myosin ensembles.

Conclusions:

• Refined mechanokinetic model parameters enhance quantitative prediction of drug effects on actomyosin function.
• The modified model provides a more robust tool for studying disease mechanisms affecting muscle contraction.
• Further research is needed to address model limitations regarding cross-bridge elasticity and small ensemble behavior.